Communiqués INVO Fertility, Inc.

Actions

IVF

US44984F8804

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 22/09/2026			Varia. 5j.	Varia. 1 janv.
0,9995 ^USD	+4,33%		+4,98%	-73,44%

20/08	INVO Fertility annonce cinq présentations par affiches soulignant la recherche sur le plasma riche en plaquettes lors du Midwest Reproductive Symposium International 2026	CI
17/08	Les plus fortes hausses en avant-Bourse	MT

Communiqués

31/08	INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference	AQ
28/08	INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference	AQ
20/08	INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International	AQ
17/08	INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability	AQ
22/06	INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure	AQ
02/06	INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q	AQ
02/06	INVO Fertility Announces Fiscal Year 2025 Financial Results	AQ
29/04	INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K	AQ
25/03	INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026	AQ
05/03	INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic	AQ
03/03	INVO Fertility’s Wisconsin Clinic Joins Progyny Network	AQ
19/02	INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”	AQ
12/02	INVO Fertility Announces Patent Issuance for Modified INVOcell Device	AQ
11/02	INVO Fertility Announces Patent Issuance for Modified INVOcell® Device	AQ
04/02	INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth	AQ
29/01	INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules	AQ
13/01	INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026	AQ
30/12	INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy	AQ
18/12	INVO Fertility : Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings"	PU
17/12	INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”	AQ
02/12	INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules	AQ
28/11	INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”	AQ
25/11	INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025	AQ
17/11	INVO Fertility Announces Third Quarter 2025 Financial Results	AQ
27/10/25	INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute	AQ